Drug Profile
VGV 1
Alternative Names: Thymus nuclear protein; TNP; VGV-1Latest Information Update: 04 Dec 2021
Price :
$50
*
At a glance
- Originator Viral Genetics
- Class Antiretrovirals; Carrier proteins
- Mechanism of Action HIV envelope protein gp41 inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 30 Nov 2012 Viral Genetics is now called VG Life Sciences
- 15 Feb 2011 Discontinued - Clinical-Phase-Unknown for HIV infections in Bulgaria (IM)
- 15 Feb 2011 Discontinued - Clinical-Phase-Unknown for HIV infections in China (IM)